Multiplikator Forward P/S: Beyond Air Inc (XAIR)
Beyond Air, Inc. (XAIR) generates revenue from the supply of LungFit PH systems to American neonatologists. The projected price-to-sales ratio reflects market expectations, where 0.40 serves as the base parameter value. Growth prospects are supported by autonomous devices that reduce the workload of medical staff, as well as the implementation of eco-friendly cylinder-free technologies and strict corporate security controls.
Ringkesan rincian data analitis beyondair.net (XAIR)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Beyond Air, Inc.|XAIR - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Beyond Air|XAIR - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku XAIR|XAIR - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Beyond Air|Rasio cepet beyondair.net
- rincian asil keuangan lan kelipatan valuasi:
XAIR - Penghasilan resik perusahaan|Bathi sing dikarepake Beyond Air, Inc.|XAIR - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Beyond Air|XAIR - Pangali PEG|Pangali EV/EBITDA XAIR|XAIR - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Beyond Air|XAIR - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan beyondair.net|XAIR - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Beyond Air, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:XAIR (AINostix)
To objectively value Beyond Air, Inc. (XAIR), managers require a forward P/S ratio that correlates current market capitalization with expected revenue, eliminating market noise and speculative volatility. By analyzing the modeled P/S of Beyond Air, Inc. (XAIR), an investor determines the asset's fair value, which is critical when assessing the scaling of medical supplies and the logistical efficiency of delivering nitric oxide delivery systems to hospitals.
Karo sapa Beyond Air, Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|INBS: Multiplikator Forward P/S|PFSA (profusa.com) - Rasio rega marang prakiraan pendapatan|SSKN (STRATA Skin Sciences Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep glucotrack.com GCTK|Multiplikator forward rega marang pendapatan NAOV (NanoVibronix)|VERO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Nuwellis, Inc. NUWE|aethlonmedical.com (AEMD) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ASXC - Rasio rega marang prakiraan pendapatan|AVGR (Avinger Inc.) - Kapitalisasi marang prakiraan pendapatan|BSGM: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan CUTR|Multiplikator forward rega marang pendapatan KNW|NARI: Rega forward marang dodolan|Multiplikator Forward P/S NVRO|Multiplikator Forward P/S reshapelifesciences.com (RSLS)|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
